
Tazo C 250mg/31.25mg Injection
Marketer
Beulah Biomedics Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Tazo C 250mg/31.25mg Injection
Ceftazidime/Clavulanate 250mg/31.25mg injection is a dual-action antibiotic. This medication combats a range of bacterial infections by inhibiting microbial growth and propagation. Administration must be overseen by a qualified medical practitioner. Consistent adherence to the prescribed dosage schedule is crucial; completing the entire course, even with symptom improvement, is vital to prevent treatment failure. Premature cessation may reduce the drug's effectiveness. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Seek immediate emergency care for allergic reactions such as skin rashes, itching, swelling, or respiratory distress. Inform your physician about all current medications before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to the risk of increased drowsiness. While driving ability is typically unaffected, refrain from driving if experiencing somnolence or dizziness. Adequate rest, balanced nutrition, and hydration are recommended for optimal recovery. Your doctor might order blood tests and other diagnostics to monitor the medication's impact.
Primary Ingredients of Tazo C 250mg/31.25mg Injection
The information is unavailable.
Uses of Tazo C 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Tazo C 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Tazo C 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Tazo C 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Tazo C 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam Injection (Tazo C 250mg/31.25mg) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Tazobactam counters bacterial resistance mechanisms, thereby boosting Ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant ingestion of alcohol and Tazo C 250mg/31.25mg Injection.
PregnancySAFE IF PRESCRIBED
Administering Tazo C Injection (250mg/31.25mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal to no negative impacts on fetal development; nevertheless, data from human clinical trials remain scarce.
Breast feedingCAUTION
Administering Tazo C 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the treatment period and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Tazo C 250mg/31.25mg Injection may induce drowsiness, visual disturbances, or dizziness. Driving is prohibited should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Tazo C 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Caution is advised when administering Tazo C 250mg/31.25mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is recommended. Dosage alteration for Tazo C 250mg/31.25mg Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Tazo C 250mg/31.25mg Injection :
Should you forget a scheduled Tazo C 250mg/31.25mg Injection, seek your physician's advice.
Facts to Know About Tazo C 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Treatment | Antimicrobial agents |
